PH24227A - Sustained released pharmaceutical compositions - Google Patents

Sustained released pharmaceutical compositions

Info

Publication number
PH24227A
PH24227A PH35906A PH35906A PH24227A PH 24227 A PH24227 A PH 24227A PH 35906 A PH35906 A PH 35906A PH 35906 A PH35906 A PH 35906A PH 24227 A PH24227 A PH 24227A
Authority
PH
Philippines
Prior art keywords
pharmaceutical compositions
sustained released
released pharmaceutical
sustained
compositions
Prior art date
Application number
PH35906A
Other languages
English (en)
Inventor
Henry C Gan
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH24227A publication Critical patent/PH24227A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
PH35906A 1986-10-09 1987-10-08 Sustained released pharmaceutical compositions PH24227A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PH24227A true PH24227A (en) 1990-05-04

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35906A PH24227A (en) 1986-10-09 1987-10-08 Sustained released pharmaceutical compositions

Country Status (24)

Country Link
JP (1) JPS63101334A (fr)
KR (1) KR880004801A (fr)
AU (1) AU7942087A (fr)
BE (1) BE1000732A5 (fr)
CA (1) CA1332809C (fr)
CH (1) CH675831A5 (fr)
DE (1) DE3733540A1 (fr)
DK (1) DK527487A (fr)
ES (1) ES2014518A6 (fr)
FI (1) FI874414A (fr)
FR (1) FR2604902B1 (fr)
GB (2) GB8624213D0 (fr)
GR (1) GR871550B (fr)
HU (1) HU201875B (fr)
IL (1) IL84104A0 (fr)
IT (1) IT1221493B (fr)
LU (1) LU87009A1 (fr)
NL (1) NL8702294A (fr)
NO (1) NO874200L (fr)
NZ (1) NZ222083A (fr)
PH (1) PH24227A (fr)
PT (1) PT85880B (fr)
SE (1) SE8703889L (fr)
ZA (1) ZA877617B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
CA2371940C (fr) * 1999-03-31 2008-07-15 Janssen Pharmaceutica N.V. Amidon pregelatinise dans une formulation a liberation regulee
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
SI1803447T1 (sl) * 2004-09-09 2010-01-29 Psicofarma S A De C V Farmacevtski sestavek za zadrĺ˝evano sproĺ äśanje hidralazina in njegova uporaba kot podrpora zdravljenju raka

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル

Also Published As

Publication number Publication date
HUT52958A (en) 1990-09-28
DK527487D0 (da) 1987-10-08
FR2604902B1 (fr) 1991-04-26
ES2014518A6 (es) 1990-07-16
LU87009A1 (fr) 1988-05-03
SE8703889D0 (sv) 1987-10-08
SE8703889L (sv) 1988-04-10
IT1221493B (it) 1990-07-06
FI874414A (fi) 1988-04-10
FI874414A0 (fi) 1987-10-07
IT8748469A0 (it) 1987-10-08
DK527487A (da) 1988-04-10
GB2195893B (en) 1991-05-08
JPS63101334A (ja) 1988-05-06
GB8723515D0 (en) 1987-11-11
ZA877617B (en) 1989-05-30
IL84104A0 (en) 1988-03-31
PT85880B (pt) 1990-07-31
GB8624213D0 (en) 1986-11-12
KR880004801A (ko) 1988-06-27
CA1332809C (fr) 1994-11-01
CH675831A5 (fr) 1990-11-15
PT85880A (en) 1987-11-01
GB2195893A (en) 1988-04-20
GR871550B (en) 1988-02-15
NO874200D0 (no) 1987-10-07
HU201875B (en) 1991-01-28
DE3733540A1 (de) 1988-04-14
NO874200L (no) 1988-04-11
AU7942087A (en) 1988-04-14
BE1000732A5 (fr) 1989-03-21
NL8702294A (nl) 1988-05-02
NZ222083A (en) 1991-05-28
FR2604902A1 (fr) 1988-04-15

Similar Documents

Publication Publication Date Title
GB2196964B (en) Pharmaceutical compositions
GB8716301D0 (en) Pharmaceutical compositions
GB8717582D0 (en) Pharmaceutical compositions
GB8723121D0 (en) Pharmaceutical compositions
GB8714625D0 (en) Pharmaceutical compositions
GB8708587D0 (en) Pharmaceutical compositions
GB8717581D0 (en) Pharmaceutical compositions
GB8618259D0 (en) Pharmaceutical compositions
GB2191696B (en) Pharmaceutical compositions
GB2190838B (en) Pharmaceutical compositions
GB8728957D0 (en) Pharmaceutical compositions
GB8723120D0 (en) Pharmaceutical compositions
PH24227A (en) Sustained released pharmaceutical compositions
GB8723118D0 (en) Pharmaceutical compositions
GB2188235B (en) Pharmaceutical compositions
GR871999B (en) Pharmaceutical compositions
GB8719387D0 (en) Pharmaceutical compositions
GB8621756D0 (en) Pharmaceutical compositions
GB8713566D0 (en) Pharmaceutical compositions
GB8624214D0 (en) Sustained release pharmaceutical compositions
GB8628476D0 (en) Pharmaceutical compositions
GB8612806D0 (en) Pharmaceutical compositions
GB8626217D0 (en) Pharmaceutical compositions
GB8626216D0 (en) Pharmaceutical compositions
GB8621085D0 (en) Pharmaceutical compositions